The title compound, 3-(4-fluorophenyl)-2-(pyridin-4-yl)pyrido[2,3-b]pyrazine (I), was prepared in the course of our studies on pyridin-4-yl-substituted pyridopyrazines as p38 mitogen-activated protein (MAP) kinase inhibitors.
In the crystal structure of the title compound, C 18 H 11 FN 4 , the pyridopyrazine ring makes dihedral angles of 34.67 (7) and 52.24 (7) with the 4-fluorophenyl and pyridine rings, respectively. The 4-fluorophenyl ring makes a dihedral angle of 59.56 (9) with the pyridine ring.
Related literature
For preparation of pyridopyrazines under microwave conditions, see: Zhao et al. (2004) .
Experimental
Crystal data C 18 H 11 FN 4 M r = 302.31 Monoclinic, P2 1 =c a = 9.7163 (9) Å b = 13.7937 (6) Å c = 10.8164 (10) (8) 0.0320 (9) 0.0011 (6) −0.0009 (6) 0.0019 (6) N2 0.0273 (7) 0.0305 (7) 0.0322 (7) −0.0026 (6) 0.0003 (6) 0.0008 (6) C3 0.0308 (9) 0.0265 (8) 0.0307 (8) −0.0022 (6) −0.0022 (7) 0.0029 (6) C4 0.0338 (9) 0.0418 (10) 0.0390 (10) −0.0094 (8) −0.0035 (7) 0.0022 (8) C5 0.0460 (11) 0.0450 (11) 0.0375 (10) −0.0158 (9) −0.0105 (8) 0.0024 (8) C6 0.0540 (12) 0.0420 (11) 0.0304 (9) −0.0102 (9) −0.0038 (8) −0.0039 (8) N7 0.0420 (9) 0.0417 (9) 0.0320 (8) −0.0044 (7) 0.0009 (6 0.0319 (9) 0.0315 (9) 0.0338 (9) 0.0008 (7) 0.0023 (7) 0.0009 (7) C13 0.0413 (10) 0.0387 (10) 0.0329 (9) −0.0040 (8) −0.0023 (7) 0.0012 (7) N14 0.0454 (9) 0.0425 (9) 0.0341 (8) −0.0067 (7) 0.0062 (7) −0.0070 (7) C15 0.0324 (9) 0.0349 (9) 0.0441 (10) −0.0043 (7) 0.0090 (8) −0.0096 (8) C16 0.0254 (8) 0.0327 (9) 0.0384 (9) −0.0022 (7) 0.0012 (7) −0.0041 (7) (9) 0.0356 (9) −0.0002 (7) 0.0010 (6) −0.0007 (7) C19 0.0341 (9) 0.0330 (9) 0.0418 (10) −0.0029 (7) −0.0028 (7) −0.0063 (7) C20 0.0263 (9) 0.0387 (10) 0.0561 (12) −0.0063 (7) −0.0085 (8) −0.0023 (9) C21 0.0235 (9) 0.0386 (10) 0.0593 (12) 0.0021 (7) 0.0004 (8) −0.0008 (9) C22 0.0285 (9) 0.0295 (9) 0.0407 (9) 0.0020 (7) 0.0024 (7) −0.0014 (7) 
